Bone Marrow News and Research

RSS

Bone Marrow is the soft, sponge-like tissue in the center of most bones. It produces white blood cells, red blood cells, and platelets.

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

The University of Texas MD Anderson Cancer Center and New Orleans-based Ochsner Health today announced a partnership to create Ochsner MD Anderson Cancer Center in southeastern Louisiana.

22 Jun 2023

Understanding the molecular mechanisms responsible for antimony drug resistance in Leishmania parasites

Leishmaniasis is a tropical disease caused by parasites known as Leishmania, which are transmitted to humans and animals through the bites of more than 90 species of sand flies.

22 Jun 2023

Repurposed drug effective at inhibiting a protein kinase linked to cardiac arrhythmias

Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.

21 Jun 2023

Newborn screening for "bubble-baby" disease boosts survival of children

Screening newborns for severe combined immunodeficiency disease (SCID) significantly increases the survival of children after bone marrow transplantation, a new North American study finds.

21 Jun 2023

Alternative splicing in neurodegenerative disease and the promise of RNA-based therapeutic strategies

Alternative splicing, a clever way a cell generates many different variations of messenger RNAs -; single-stranded RNAs involved in protein synthesis -; and proteins from the same stretch of DNA, plays an important role in molecular biology.

21 Jun 2023

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

Introducing widespread screening of newborns for a deadly disease called severe combined immunodeficiency, or SCID, followed by early treatment boosted the five-year survival rate of children with the disorder from 73% before the advent of screening to 87% since, researchers report.

20 Jun 2023

Could mutated blood cells hold the key to lower Alzheimer's risk?

Researchers tested whether clonal hematopoiesis of indeterminate potential (CHIP) status was associated with Alzheimer's disease.

19 Jun 2023

Trained immunity: its role in COVID-19 and potential in preparing for future infectious outbreaks

Researchers reported on the contribution of trained immune responses to protection against SARS-CoV-2 infections and future pandemics.

16 Jun 2023

Moderate exercise can influence the inflammatory responses of macrophages, research shows

Researchers have long known that moderate exercise has a beneficial impact on the body's response to inflammation, but what's been less understood is why.

15 Jun 2023

New base-edited T-cells proven effective to treat lymphoblastic leukemia

Three young patients with relapsed T-cell leukemia have now been treated with base-edited T-cells, as part of a 'bench-to-bedside' collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).

15 Jun 2023

Understanding the developmental link: vitamin D's role in metabolic disease risk

Study showed that transplanting fetal hematopoietic stem cells exposed to vitamin D deficiency induces diabetes.

14 Jun 2023

Common weight-loss surgery for obese adolescents and young adults reduces bone strength

A common weight-loss surgery for obese adolescents and young adults is found to have harmful effects on bones, according to a study published in Radiology, a journal of the Radiological Society of North America.

13 Jun 2023

Study offers novel insights into the evolution of multiple myeloma

A new study by researchers at The University of Texas MD Anderson Cancer Center highlights novel insights into the evolution of multiple myeloma from precursor disease, which may help better identify patients likely to progress and develop new interventions.

12 Jun 2023

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

Humanigen, Inc.today extended previously reported results by presenting additional, statistically significant hematologic improvements and reductions in inflammatory markers from lenzilumab, its investigational drug, in a Phase 2/3 trial of treatment-naïve participants with chronic myelomonocytic leukemia and RAS-pathway mutations.

9 Jun 2023

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.

5 Jun 2023

Bone Marrow News and Research

Further Reading

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

Understanding the molecular mechanisms responsible for antimony drug resistance in Leishmania parasites

Repurposed drug effective at inhibiting a protein kinase linked to cardiac arrhythmias

Newborn screening for "bubble-baby" disease boosts survival of children

Alternative splicing in neurodegenerative disease and the promise of RNA-based therapeutic strategies

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

Could mutated blood cells hold the key to lower Alzheimer's risk?

Trained immunity: its role in COVID-19 and potential in preparing for future infectious outbreaks

Moderate exercise can influence the inflammatory responses of macrophages, research shows

New base-edited T-cells proven effective to treat lymphoblastic leukemia

Understanding the developmental link: vitamin D's role in metabolic disease risk

Common weight-loss surgery for obese adolescents and young adults reduces bone strength

Study offers novel insights into the evolution of multiple myeloma

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Research opens door to new, more efficient drug combinations for acute myeloid leukemia

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

AI interpretations of MRI images could provide more accurate RA prediction

The immunopathology of post-acute sequelae of SARS-CoV-2 infection: highlighting the knowledge gaps

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News